|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
WAVE Life Sciences (WVE)
Trading: SELL @ $7.77
Signal Strength: STRONG
Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.
WAVE Life Sciences (NASDAQ:WVE) is currently bearish highlighting the potential for a short term trend continuation in the downward direction.
The Donchian channel is a useful indicator for seeing the volatility of a market price. If a price is stable the Donchian channel will be relatively narrow. If the price fluctuates a lot the Donchian channel will be wider. The two outer bands are plotted as the highest high and lowest low for a set period originally 20 days with the optional middle band calculated as the average of the two.
Calculation: Donchian Channels:
1) Upper Channel = 20 Day High;
2) Lower Channel = 20 Day Low;
3) Middle Channel = (20 Day High + 20 Day Low)/2;
PROFILE: WAVE Life Sciences (WVE)
Stock Exchange: NASDAQ
Company: WAVE Life Sciences
Ticker Codes: | WVE | NASDAQ:WVE |
Wave Life Sciences Ltd., a biotechnology company, designs, develops, and commercializes nucleic acid therapeutic candidates for genetically defined diseases by utilizing proprietary synthetic chemistry drug development platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics, as well as a collaboration agreement with Deep Genomics Inc. for identifying novel therapies. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
|FARM Farmer Brothers||13.38||4.4||116,584||-18.79||BEARISH|
|TRUP Trupanion Inc||33.32||4.2||261,897||-9.7||BEARISH|
|BCOR Blucora Inc||23.41||3.2||401,986||-24.7||BEARISH|
|VSEC VSE Corporation||34.74||3||14,243||-23.15||BEARISH|
|VRAY Viewray Inc||3.06||3||3,697,594||-25.47||BEARISH|
|ALGN Align Technology||279.31||2.2||795,665||-19.4||BEARISH|
|NTLA Intellia Therapeutics||14.64||1.9||548,959||-6.62||BEARISH|
|MYRG MYR Group||32.39||1.8||66,670||-11.27||BEARISH|